Abiraterone
The serum concentration of Rasagiline can be increased when it is combined with Abiraterone.
Acarbose
Rasagiline may increase the hypoglycemic activities of Acarbose.
Acebutolol
Rasagiline may increase the hypotensive activities of Acebutolol.
Advertisement
Acepromazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Aceprometazine.
Acetophenazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Acetophenazine.
Advertisement
Albiglutide
Rasagiline may increase the hypoglycemic activities of Albiglutide.
Albuterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Aldesleukin.
Advertisement
Alfentanil
Rasagiline may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Alfentanil.
Aliskiren
Rasagiline may increase the hypotensive activities of Aliskiren.
Almotriptan
The serum concentration of Almotriptan can be increased when it is combined with Rasagiline.
Alogliptin
Rasagiline may increase the hypoglycemic activities of Alogliptin.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Rasagiline.
Alprenolol
Rasagiline may increase the hypotensive activities of Alprenolol.
Altretamine
Altretamine may increase the orthostatic hypotensive activities of Rasagiline.
Ambrisentan
Rasagiline may increase the hypotensive activities of Ambrisentan.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Rasagiline.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Rasagiline.
Amiloride
The risk or severity of adverse effects can be increased when Rasagiline is combined with Amiloride.
Amineptin
Rasagiline may increase the serotonergic activities of Amineptine.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Rasagiline.
Amisulpride
The risk or severity of adverse effects can be increased when Rasagiline is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Rasagiline.
Amlodipine
Rasagiline may increase the hypotensive activities of Amlodipine.
Amobarbital
Amobarbital may increase the hypotensive activities of Rasagiline.
Amoxapine
Rasagiline may increase the serotonergic activities of Amoxapine.
Amphetamine
Rasagiline may increase the hypertensive activities of Amphetamine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Rasagiline.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Rasagiline.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Rasagiline is combined with Amyl Nitrite.
Apomorphine
The metabolism of Apomorphine can be decreased when combined with Rasagiline.
Apraclonidine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Apraclonidine.
Arbutamine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Arbutamine.
Arformoterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Rasagiline.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Rasagiline.
Asenapine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Asenapine.
Atenolol
Rasagiline may increase the hypotensive activities of Atenolol.
Atomoxetine
Rasagiline may increase the central neurotoxic activities of Atomoxetine.
Atropine
Rasagiline may increase the hypertensive activities of Atropine.
Azilsartan
The risk or severity of adverse effects can be increased when Rasagiline is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Rasagiline is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Rasagiline is combined with Azilsartan medoxomil.
Azithromycin
The metabolism of Rasagiline can be decreased when combined with Azithromycin.
Bambuterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Bambuterol.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Rasagiline.
Barbital
Barbital may increase the hypotensive activities of Rasagiline.
Benazepril
Rasagiline may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Rasagiline may increase the hypotensive activities of Bendroflumethiazide.
Benperidol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Benperidol.
Benzphetamine
Rasagiline may increase the hypertensive activities of Benzphetamine.
Bepridil
Rasagiline may increase the hypotensive activities of Bepridil.
BETAHISTINE
The serum concentration of Betahistine can be increased when it is combined with Rasagiline.
Betaxolol
Rasagiline may increase the hypotensive activities of Betaxolol.
Bethanidine
Rasagiline may increase the hypotensive activities of Bethanidine.
Bezafibrate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Bezafibrate.
Bimatoprost
Rasagiline may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Rasagiline may increase the hypotensive activities of Bisoprolol.
Bortezomib
The metabolism of Rasagiline can be decreased when combined with Bortezomib.
Bosentan
Rasagiline may increase the hypotensive activities of Bosentan.
Bretylium
Rasagiline may increase the hypotensive activities of Bretylium.
Brexpiprazole
The risk or severity of adverse effects can be increased when Rasagiline is combined with Brexpiprazole.
Brimonidine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Brimonidine.
Bromocriptine
The metabolism of Bromocriptine can be decreased when combined with Rasagiline.
Bromperidol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Bromperidol.
Bumetanide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Rasagiline.
Bupranolol
Rasagiline may increase the hypotensive activities of Bupranolol.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Rasagiline.
Bupropion
The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Buspirone.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Rasagiline.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Rasagiline.
Cafedrine
Rasagiline may increase the hypotensive activities of Cafedrine.
Caffeine
The metabolism of Rasagiline can be decreased when combined with Caffeine.
Canagliflozin
Rasagiline may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Rasagiline may increase the hypoglycemic activities of Canagliflozin.
Candesartan
Rasagiline may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Rasagiline may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Rasagiline may increase the hypotensive activities of Captopril.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Rasagiline.
Cariprazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Cariprazine.
Carteolol
Rasagiline may increase the hypotensive activities of Carteolol.
Carvedilol
Rasagiline may increase the hypotensive activities of Carvedilol.
Celiprolol
Rasagiline may increase the hypotensive activities of Celiprolol.
Chlorothiazide
Rasagiline may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Rasagiline.
Chlorpropamide
Rasagiline may increase the hypoglycemic activities of Chlorpropamide.
Chlorprothixene
The risk or severity of adverse effects can be increased when Rasagiline is combined with Chlorprothixene.
Chlorthalidone
Rasagiline may increase the hypotensive activities of Chlorthalidone.
Cicletanine
Rasagiline may increase the hypotensive activities of Cicletanine.
Cilazapril
Rasagiline may increase the hypotensive activities of Cilazapril.
Citalopram
The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.
Clemastine
Rasagiline may increase the anticholinergic activities of Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Clenbuterol.
Clevidipine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Rasagiline.
Clomipramine
Rasagiline may increase the serotonergic activities of Clomipramine.
Clonidine
Rasagiline may increase the hypotensive activities of Clonidine.
Clotrimazole
The metabolism of Rasagiline can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Rasagiline.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Rasagiline.
Cryptenamine
Rasagiline may increase the hypotensive activities of Cryptenamine.
Cyamemazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Cyamemazine.
Cyclobenzaprine
Cyclobenzaprine may increase the serotonergic activities of Rasagiline.
Cyclopenthiazide
Rasagiline may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Rasagiline may increase the hypotensive activities of Cyclothiazide.
Cyproheptadine
Rasagiline may increase the anticholinergic activities of Cyproheptadine.
Cyproterone Acetate
The serum concentration of Rasagiline can be decreased when it is combined with Cyproterone acetate.
Dapagliflozin
Rasagiline may increase the hypoglycemic activities of Dapagliflozin.
Dapiprazole
The risk or severity of adverse effects can be increased when Rasagiline is combined with Dapiprazole.
Debrisoquin
Rasagiline may increase the hypotensive activities of Debrisoquin.
Deferasirox
The serum concentration of Rasagiline can be increased when it is combined with Deferasirox.
Deserpidine
Rasagiline may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Rasagiline.
Desipramine
Rasagiline may increase the serotonergic activities of Desipramine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Rasagiline.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Deutetrabenazine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Dexmedetomidine.
Dexmethylphenidate
Rasagiline may increase the hypertensive activities of Dexmethylphenidate.
Dextroamphetamine
Rasagiline may increase the hypertensive activities of Dextroamphetamine.
Dextromethorphan
Rasagiline may increase the serotonergic activities of Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Rasagiline.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Rasagiline.
Diazoxide
Rasagiline may increase the hypotensive activities of Diazoxide.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Diclofenamide.
Diethylpropion
Rasagiline may increase the hypertensive activities of Diethylpropion.
Dihydralazine
Rasagiline may increase the hypotensive activities of Dihydralazine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Rasagiline.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Rasagiline.
Diltiazem
Rasagiline may increase the hypotensive activities of Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Rasagiline is combined with Dinutuximab.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Rasagiline.
Dipivefrin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Dipivefrin.
Dipyridamole
The risk or severity of adverse effects can be increased when Rasagiline is combined with Dipyridamole.
Disopyramide
Rasagiline may increase the hypoglycemic activities of Disopyramide.
Disulfiram
The risk or severity of convulsion can be increased when Rasagiline is combined with Disulfiram.
Dobutamine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Dobutamine.
Dolasetron
Dolasetron may increase the serotonergic activities of Rasagiline.
Domperidone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Domperidone.
Dorzolamide
Rasagiline may increase the hypotensive activities of Dorzolamide.
Dothiepin
The serum concentration of Rasagiline can be increased when it is combined with Dosulepin.
Doxapram
Rasagiline may increase the hypertensive activities of Doxapram.
Doxazosin
Rasagiline may increase the hypotensive activities of Doxazosin.
Doxepin
Rasagiline may increase the serotonergic activities of Doxepin.
Doxylamine
Rasagiline may increase the anticholinergic activities of Doxylamine.
Droperidol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Droperidol.
Droxidopa
The risk or severity of adverse effects can be increased when Rasagiline is combined with Droxidopa.
Dulaglutide
Rasagiline may increase the hypoglycemic activities of Dulaglutide.
Duloxetine
Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.
Eletriptan
The serum concentration of Eletriptan can be increased when it is combined with Rasagiline.
Empagliflozin
Rasagiline may increase the hypoglycemic activities of Empagliflozin.
Enalapril
Rasagiline may increase the hypotensive activities of Enalapril.
Enalaprilat
Rasagiline may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Rasagiline may increase the hypotensive activities of Enalaprilat.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Rasagiline.
Epinephrine
Rasagiline may increase the hypertensive activities of Epinephrine.
Eplerenone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Eplerenone.
Epoprostenol
Rasagiline may increase the hypotensive activities of Epoprostenol.
Eprosartan
Rasagiline may increase the hypotensive activities of Eprosartan.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rasagiline.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Rasagiline.
Ergotamine
Rasagiline may increase the hypertensive activities of Ergotamine.
Escitalopram
The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.
Esmolol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Esmolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Rasagiline is combined with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Rasagiline.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Rasagiline.
Exenatide
Rasagiline may increase the hypoglycemic activities of Exenatide.
Felodipine
Rasagiline may increase the hypotensive activities of Felodipine.
Fenfluramine
Rasagiline may increase the serotonergic activities of Fenfluramine.
Fenoldopam
Rasagiline may increase the hypotensive activities of Fenoldopam.
Fenoterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Fenoterol.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Rasagiline.
Ferulic Acid
Rasagiline may increase the hypotensive activities of Ferulic acid.
Fluoxetine
The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.
Flupenthixol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Fluphenazine.
Fluspirilene
The risk or severity of adverse effects can be increased when Rasagiline is combined with Fluspirilene.
Fluvoxamine
The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.
Formoterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Formoterol.
Fosinopril
Rasagiline may increase the hypotensive activities of Fosinopril.
Frovatriptan
The serum concentration of Frovatriptan can be increased when it is combined with Rasagiline.
Furazolidone
Rasagiline may increase the hypertensive activities of Furazolidone.
Furosemide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Furosemide.
Gliclazide
Rasagiline may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Rasagiline may increase the hypoglycemic activities of Glimepiride.
Glipizide
Rasagiline may increase the hypoglycemic activities of Glipizide.
Glyburide
Rasagiline may increase the hypoglycemic activities of Glyburide.
Granisetron
Granisetron may increase the serotonergic activities of Rasagiline.
Guanabenz
Rasagiline may increase the hypotensive activities of Guanabenz.
Guanadrel
Rasagiline may increase the hypotensive activities of Guanadrel.
Guanethidine
Rasagiline may increase the hypotensive activities of Guanethidine.
Guanfacine
Rasagiline may increase the hypotensive activities of Guanfacine.
Haloperidol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Rasagiline.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Rasagiline.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Rasagiline.
Hydralazine
Rasagiline may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Rasagiline may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Rasagiline.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Rasagiline.
Hydroflumethiazide
Rasagiline may increase the hypotensive activities of Hydroflumethiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Rasagiline.
Iloperidone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Rasagiline.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Rasagiline.
Imipramine
Rasagiline may increase the serotonergic activities of Imipramine.
Indacaterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Indacaterol.
Indapamide
Rasagiline may increase the hypotensive activities of Indapamide.
Indoramin
Rasagiline may increase the hypotensive activities of Indoramin.
Insulin Detemir
Rasagiline may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Rasagiline may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Rasagiline may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Rasagiline may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Rasagiline may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Rasagiline may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Rasagiline may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Rasagiline may increase the hypoglycemic activities of Insulin Lispro.
Iproniazid
Rasagiline may increase the hypertensive activities of Iproniazid.
Irbesartan
Rasagiline may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypertensive activities of Rasagiline.
Isoetharine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Rasagiline.
Isometheptene
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isometheptene.
Isoproterenol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isoxsuprine.
Isradipine
Rasagiline may increase the hypotensive activities of Isradipine.
Ketanserin
Rasagiline may increase the hypotensive activities of Ketanserin.
Labetalol
Rasagiline may increase the hypotensive activities of Labetalol.
Lacidipine
Rasagiline may increase the hypotensive activities of Lacidipine.
Latanoprost
Rasagiline may increase the hypotensive activities of Latanoprost.
Lercanidipine
Rasagiline may increase the hypotensive activities of Lercanidipine.
Levalbuterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Levosalbutamol.
Levobunolol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Rasagiline.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Rasagiline.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Rasagiline.
Levomilnacipran
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Rasagiline.
Levonordefrin
Rasagiline may increase the hypertensive activities of Levonordefrin.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Rasagiline.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Rasagiline.
Lidocaine
The metabolism of Rasagiline can be decreased when combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Rasagiline is combined with Linezolid.
Liraglutide
Rasagiline may increase the hypoglycemic activities of Liraglutide.
Lisdexamfetamine
Rasagiline may increase the hypertensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Rasagiline may increase the hypertensive activities of Lisdexamfetamine.
Lisinopril
Rasagiline may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Rasagiline may increase the hypotensive activities of Lisinopril.
Lisuride
The metabolism of Lisuride can be decreased when combined with Rasagiline.
Lithium
The risk or severity of adverse effects can be increased when Rasagiline is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Rasagiline is combined with Lithium.
Lofexidine
Rasagiline may increase the hypotensive activities of Lofexidine.
Lorcaserin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Lorcaserin.
Losartan
Rasagiline may increase the hypotensive activities of Losartan.
Loxapine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Loxapine.
Lurasidone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Lurasidone.
Macitentan
Rasagiline may increase the hypotensive activities of Macitentan.
Manidipine
Rasagiline may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Maprotiline.
Mecamylamine
Rasagiline may increase the hypotensive activities of Mecamylamine.
Mecasermin
Rasagiline may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Rasagiline may increase the hypoglycemic activities of Mecasermin.
Meperidine
Rasagiline may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Mephentermine
Rasagiline may increase the hypertensive activities of Mephentermine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Rasagiline.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Rasagiline.
Mequitazine
Rasagiline may increase the anticholinergic activities of Mequitazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Mesoridazine.
Metaproterenol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Orciprenaline.
Metaraminol
Rasagiline may increase the hypertensive activities of Metaraminol.
Metformin
Rasagiline may increase the hypoglycemic activities of Metformin.
Methadone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Rasagiline.
Methamphetamine
Rasagiline may increase the hypertensive activities of Methamphetamine.
Methazolamide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Rasagiline.
Methotrimeprazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Methotrimeprazine.
Methoxamine
Rasagiline may increase the hypertensive activities of Methoxamine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Methyclothiazide.
Methyldopa
The risk or severity of hypertension can be increased when Rasagiline is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of hypertension can be increased when Rasagiline is combined with Methyldopa.
Methylene blue
Rasagiline may increase the serotonergic activities of Methylene blue.
Methylphenidate
Rasagiline may increase the hypertensive activities of Methylphenidate.
Metipranolol
Rasagiline may increase the hypotensive activities of Metipranolol.
Metoclopramide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Metoclopramide.
Metolazone
Rasagiline may increase the hypotensive activities of Metolazone.
Metoprolol
Rasagiline may increase the hypotensive activities of Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Rasagiline is combined with Melperone.
Metyrosine
Rasagiline may increase the hypotensive activities of Metyrosine.
Mexiletine
The serum concentration of Rasagiline can be increased when it is combined with Mexiletine.
Mianserin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Mianserin.
Mibefradil
Rasagiline may increase the hypotensive activities of Mibefradil.
Midodrine
Rasagiline may increase the hypertensive activities of Midodrine.
Midostaurin
The serum concentration of Rasagiline can be increased when it is combined with Midostaurin.
Mifepristone
Rasagiline may increase the hypoglycemic activities of Mifepristone.
Miglitol
Rasagiline may increase the hypoglycemic activities of Miglitol.
Milnacipran
The risk or severity of adverse effects can be increased when Milnacipran is combined with Rasagiline.
Minaprine
Rasagiline may increase the hypertensive activities of Minaprine.
Minoxidil
Rasagiline may increase the hypotensive activities of Minoxidil.
Mirtazapine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Moclobemide.
Moexipril
Rasagiline may increase the hypotensive activities of Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Molindone.
Morphine
The therapeutic efficacy of Morphine can be increased when used in combination with Rasagiline.
Moxonidine
Rasagiline may increase the hypotensive activities of Moxonidine.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Rasagiline.
Nadolol
Rasagiline may increase the hypotensive activities of Nadolol.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rasagiline.
Naratriptan
The serum concentration of Naratriptan can be increased when it is combined with Rasagiline.
Nateglinide
Rasagiline may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Rasagiline may increase the hypotensive activities of Nebivolol.
Nefazodone
The risk or severity of adverse effects can be increased when Nefazodone is combined with Rasagiline.
Nesiritide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Nesiritide.
Nevirapine
The metabolism of Rasagiline can be decreased when combined with Nevirapine.
Nialamide
Rasagiline may increase the hypertensive activities of Nialamide.
Nicardipine
Rasagiline may increase the hypotensive activities of Nicardipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Rasagiline.
Nifedipine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Nifedipine.
Nilvadipine
Rasagiline may increase the hypotensive activities of Nilvadipine.
Nimodipine
Rasagiline may increase the hypotensive activities of Nimodipine.
Nisoldipine
Rasagiline may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Rasagiline may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Rasagiline.
Nitroglycerin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Nitroglycerin.
Nitroprusside
Rasagiline may increase the hypotensive activities of Nitroprusside.
Norepinephrine
Rasagiline may increase the hypertensive activities of Norepinephrine.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Rasagiline.
Nortriptyline
Rasagiline may increase the serotonergic activities of Nortriptyline.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Rasagiline.
Olanzapine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Olanzapine.
Olmesartan
Rasagiline may increase the hypotensive activities of Olmesartan.
Olodaterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Olodaterol.
Ondansetron
Ondansetron may increase the serotonergic activities of Rasagiline.
Opipramol
Rasagiline may increase the serotonergic activities of Opipramol.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Rasagiline.
Osimertinib
The serum concentration of Rasagiline can be decreased when it is combined with Osimertinib.
Oxprenolol
Rasagiline may increase the hypotensive activities of Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Rasagiline.
p-Hydroxyamphetamine
Rasagiline may increase the hypertensive activities of Hydroxyamphetamine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Rasagiline.
Paliperidone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Rasagiline.
Papaverine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Papaverine.
Paregoric
The therapeutic efficacy of Morphine can be increased when used in combination with Rasagiline.
Pargyline
Rasagiline may increase the hypertensive activities of Pargyline.
Paroxetine
The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.
Peginterferon Alfa-2b
The serum concentration of Rasagiline can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
Rasagiline may increase the hypotensive activities of Penbutolol.
Pentamidine
Rasagiline may increase the hypoglycemic activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Rasagiline.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Rasagiline.
Perazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Perazine.
Pergolide
The metabolism of Pergolide can be decreased when combined with Rasagiline.
Periciazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Propericiazine.
Perindopril
Rasagiline may increase the hypotensive activities of Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Perphenazine.
Phenelzine
Phenelzine may increase the hypertensive activities of Rasagiline.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Rasagiline.
Phenoxybenzamine
Rasagiline may increase the hypotensive activities of Phenoxybenzamine.
Phentermine
Rasagiline may increase the hypertensive activities of Phentermine.
PHENTERMINE RESIN
Rasagiline may increase the hypertensive activities of Phentermine.
Phentolamine
Rasagiline may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Rasagiline may increase the hypotensive activities of Phentolamine.
Phenylephrine
Rasagiline may increase the hypertensive activities of Phenylephrine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Phenylpropanolamine.
Pholcodine
Pholcodine may increase the serotonergic activities of Rasagiline.
Pimozide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Pimozide.
Pinacidil
Rasagiline may increase the hypotensive activities of Pinacidil.
Pindolol
Rasagiline may increase the hypotensive activities of Pindolol.
Pioglitazone
Rasagiline may increase the hypoglycemic activities of Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Rasagiline.
Pipothiazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Pipotiazine.
Pirbuterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Pirbuterol.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Rasagiline.
Pizotyline
Rasagiline may increase the anticholinergic activities of Pizotifen.
Polythiazide
Rasagiline may increase the hypotensive activities of Polythiazide.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Rasagiline.
Pramlintide
Rasagiline may increase the hypoglycemic activities of Pramlintide.
Prazosin
Rasagiline may increase the hypotensive activities of Prazosin.
Primidone
Primidone may increase the hypotensive activities of Rasagiline.
Procarbazine
Rasagiline may increase the hypertensive activities of Procarbazine.
Procaterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Procaterol.
Prochlorperazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Prochlorperazine.
Promazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Rasagiline.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Rasagiline.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Rasagiline.
Propranolol
Rasagiline may increase the hypotensive activities of Propranolol.
Prothipendyl
The risk or severity of adverse effects can be increased when Rasagiline is combined with Prothipendyl.
Protriptyline
Rasagiline may increase the serotonergic activities of Protriptyline.
Pseudoephedrine
Rasagiline may increase the hypertensive activities of Pseudoephedrine.
Quetiapine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Quetiapine.
Quinapril
Rasagiline may increase the hypotensive activities of Quinapril.
Quinine
Rasagiline may increase the hypoglycemic activities of Quinine.
Ramipril
Rasagiline may increase the hypotensive activities of Ramipril.
Regular Insulin, Human
Rasagiline may increase the hypoglycemic activities of Insulin Human.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Rasagiline.
Remoxipride
The risk or severity of adverse effects can be increased when Rasagiline is combined with Remoxipride.
Repaglinide
Rasagiline may increase the hypoglycemic activities of Repaglinide.
Rescinnamine
Rasagiline may increase the hypotensive activities of Rescinnamine.
Reserpine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Reserpine.
Rilmenidine
Rasagiline may increase the hypotensive activities of Rilmenidine.
Riociguat
Rasagiline may increase the hypotensive activities of Riociguat.
Risperidone
Rasagiline may increase the hypotensive activities of Risperidone.
Ritodrine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Ritodrine.
Rizatriptan
The serum concentration of Rizatriptan can be increased when it is combined with Rasagiline.
Ropinirole
The risk or severity of adverse effects can be increased when Rasagiline is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Ropivacaine.
Rosiglitazone
Rasagiline may increase the hypoglycemic activities of Rosiglitazone.
Rotigotine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Rotigotine.
Rucaparib
The metabolism of Rasagiline can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Rasagiline is combined with Sacubitril.
Salmeterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Salmeterol.
Saxagliptin
Rasagiline may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Rasagiline may increase the hypoglycemic activities of Saxagliptin.
Secobarbital
Secobarbital may increase the hypotensive activities of Rasagiline.
Selegiline
Selegiline may increase the hypertensive activities of Rasagiline.
Selexipag
Rasagiline may increase the hypotensive activities of Selexipag.
Sertindole
The risk or severity of adverse effects can be increased when Rasagiline is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.
Sevoflurane
The risk or severity of adverse effects can be increased when Rasagiline is combined with Sevoflurane.
Simeprevir
The metabolism of Rasagiline can be decreased when combined with Simeprevir.
Sitagliptin
Rasagiline may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Rasagiline may increase the hypoglycemic activities of Sitagliptin.
Sotalol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Sotalol.
Spirapril
Rasagiline may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Rasagiline is combined with Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Rasagiline.
Sulfadiazine
Rasagiline may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Rasagiline may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Rasagiline may increase the hypoglycemic activities of Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Rasagiline is combined with Sulpiride.
Sumatriptan
The serum concentration of Sumatriptan can be increased when it is combined with Rasagiline.
Sumatriptan Succinate
The serum concentration of Sumatriptan can be increased when it is combined with Rasagiline.
Sunitinib
Rasagiline may increase the hypoglycemic activities of Sunitinib.
Talinolol
Rasagiline may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Tamsulosin.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Rasagiline.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Rasagiline.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Rasagiline.
Telmisartan
Rasagiline may increase the hypotensive activities of Telmisartan.
Tenofovir Disoproxil
The metabolism of Rasagiline can be decreased when combined with Tenofovir disoproxil.
Terazosin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Terazosin.
Terbutaline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.
Teriflunomide
The serum concentration of Rasagiline can be decreased when it is combined with Teriflunomide.
Terlipressin
Rasagiline may increase the hypotensive activities of Terlipressin.
Testosterone Propionate
The risk or severity of adverse effects can be increased when Testosterone propionate is combined with Rasagiline.
Tetrabenazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Tetrabenazine.
Tetrahydrozoline
Rasagiline may increase the hypertensive activities of Tetryzoline.
Thalidomide
The risk or severity of adverse effects can be increased when Rasagiline is combined with Thalidomide.
Theodrenaline
Rasagiline may increase the hypotensive activities of Theodrenaline.
Theophylline
The metabolism of Rasagiline can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Rasagiline can be decreased when combined with Theophylline.
Thiamylal
Thiamylal may increase the hypotensive activities of Rasagiline.
Thiopental
Thiopental may increase the hypotensive activities of Rasagiline.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Rasagiline.
Thioproperazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Thioproperazine.
Thioridazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Rasagiline is combined with Thiothixene.
Tianeptine
The risk or severity of adverse effects can be increased when Tianeptine is combined with Rasagiline.
Tiapride
The risk or severity of adverse effects can be increased when Rasagiline is combined with Tiapride.
Tibolone
Rasagiline may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Rasagiline can be decreased when combined with Ticlopidine.
Timolol
Rasagiline may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Rasagiline may increase the hypotensive activities of Timolol.
Tizanidine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Tizanidine.
Tolazamide
Rasagiline may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Rasagiline may increase the hypotensive activities of Tolazoline.
Tolbutamide
Rasagiline may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Rasagiline.
Toloxatone
Rasagiline may increase the hypertensive activities of Toloxatone.
Torsemide
Rasagiline may increase the hypotensive activities of Torasemide.
Tramadol
Tramadol may increase the neuroexcitatory activities of Rasagiline.
Trandolapril
Rasagiline may increase the hypotensive activities of Trandolapril.
Tranylcypromine
Tranylcypromine may increase the hypertensive activities of Rasagiline.
Travoprost
Rasagiline may increase the hypotensive activities of Travoprost.
Trazodone
Rasagiline may increase the serotonergic activities of Trazodone.
Treprostinil
Rasagiline may increase the hypotensive activities of Treprostinil.
Tretinoin
The risk or severity of adverse effects can be increased when Rasagiline is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Rasagiline is combined with Triamterene.
Trichlormethiazide
Rasagiline may increase the hypotensive activities of Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Triflupromazine.
Trimethaphan
Rasagiline may increase the hypotensive activities of Trimethaphan.
Trimipramine
Rasagiline may increase the serotonergic activities of Trimipramine.
Tropisetron
Tropisetron may increase the serotonergic activities of Rasagiline.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Rasagiline.
UNOPROSTONE
Rasagiline may increase the hypotensive activities of Unoprostone.
Urapidil
Rasagiline may increase the hypotensive activities of Urapidil.
Valsartan
Rasagiline may increase the hypotensive activities of Valsartan.
Vemurafenib
The serum concentration of Rasagiline can be increased when it is combined with Vemurafenib.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.
Verapamil
The risk or severity of adverse effects can be increased when Rasagiline is combined with Verapamil.
Vilanterol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Vilanterol.
Vilazodone
The metabolism of Vilazodone can be decreased when combined with Rasagiline.
Vincamine
Rasagiline may increase the hypotensive activities of Vincamine.
Vinpocetine
Rasagiline may increase the hypotensive activities of Vinpocetine.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Rasagiline.
Xylometazoline
Rasagiline may increase the hypotensive activities of Xylometazoline.
Ziprasidone
The risk or severity of adverse effects can be increased when Rasagiline is combined with Ziprasidone.
Zofenopril
Rasagiline may increase the hypotensive activities of Zofenopril.
Zolmitriptan
The serum concentration of Zolmitriptan can be increased when it is combined with Rasagiline.
Zotepine
The risk or severity of adverse effects can be increased when Rasagiline is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Rasagiline is combined with Zuclopenthixol.
